WCA
WST icon

Westover Capital Advisors’s West Pharmaceutical WST Stock Holding History

Westover Capital Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Hold
1,120
– – 0.07% 175
2026
Q1 		$281K Hold
1,120
– – 0.05% 202
2025
Q4 		$308K Hold
1,120
– – 0.06% 196
2025
Q3 		$294K Hold
1,120
– – 0.05% 188
2025
Q2 		$245K Hold
1,120
– – 0.05% 203
2025
Q1 		$251K Hold
1,120
– – 0.06% 206
2024
Q4 		$367K Sell
1,120
-8
-0.7% -$2.52K 0.08% 169
2024
Q3 		$339K Hold
1,128
– – 0.07% 189
2024
Q2 		$372K Sell
1,128
-132
-10% -$46.6K 0.1% 158
2024
Q1 		$499K Sell
1,260
-140
-10% -$51.8K 0.15% 112
2023
Q4 		$493K Hold
1,400
– – 0.16% 104
2023
Q3 		$525K Hold
1,400
– – 0.19% 97
2023
Q2 		$535K Hold
1,400
– – 0.19% 98
2023
Q1 		$485K Hold
1,400
– – 0.18% 97
2022
Q4 		$329K Hold
1,400
– – 0.13% 111
2022
Q3 		$345K Hold
1,400
– – 0.13% 109
2022
Q2 		$423K Hold
1,400
– – 0.16% 104
2022
Q1 		$575K Hold
1,400
– – 0.18% 100
2021
Q4 		$657K Hold
1,400
– – 0.19% 95
2021
Q3 		$594K Hold
1,400
– – 0.19% 93
2021
Q2 		$503K Hold
1,400
– – 0.16% 102
2021
Q1 		$394K Hold
1,400
– – 0.14% 113
2020
Q4 		$397K Hold
1,400
– – 0.14% 106
2020
Q3 		$385K Hold
1,400
– – 0.16% 97
2020
Q2 		$318K Hold
1,400
– – 0.15% 91
2020
Q1 		$213K Hold
1,400
– – 0.12% 109
2019
Q4 		$210K Buy
+1,400
New +$204K 0.09% 136

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Westover Capital Advisors's WST Position: Q2 2026 in Review

Westover Capital Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,120 shares worth $402K. The position accounts for 0.07% of the portfolio, ranked #175.

Westover Capital Advisors first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $657K in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Westover Capital Advisors held 1,120 shares of West Pharmaceutical worth $402K as of Q2 2026.
  • Westover Capital Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.07% of Westover Capital Advisors's portfolio in Q2 2026, its #175 holding.
  • Westover Capital Advisors first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Westover Capital Advisors's West Pharmaceutical position peaked at $657K in Q4 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Westover Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.